Bonduelle SCA
Bonduelle SCA engages in the provision of plant-based food in Europe and internationally. The company operates through two segments, Europe Zone and Non-Europe Zone. It offers canned, frozen, and ready-to-use fresh vegetables under the Bonduelle, Cassegrain, Globus, and Ready Pac Foods brands. The company was founded in 1853 and is headquartered in Renescure, France.
Bonduelle SCA (BDU) - Total Liabilities
Latest total liabilities as of June 2025: €1.38 Billion EUR
Based on the latest financial reports, Bonduelle SCA (BDU) has total liabilities worth €1.38 Billion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bonduelle SCA - Total Liabilities Trend (2014–2025)
This chart illustrates how Bonduelle SCA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bonduelle SCA Competitors by Total Liabilities
The table below lists competitors of Bonduelle SCA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ECARX Holdings Inc. Class A Ordinary shares
NASDAQ:ECX
|
USA | $6.61 Billion |
|
Globus Spirits Limited
NSE:GLOBUSSPR
|
India | ₹11.42 Billion |
|
Enwei Pharmaceutical Co. Ltd. A
SHE:301331
|
China | CN¥433.11 Million |
|
Oncolytics Biotech Inc
NASDAQ:ONCY
|
USA | $14.94 Million |
|
Smartoptics Group AS
OL:SMOP
|
Norway | Nkr23.55 Million |
|
Shenzhen Properties & Resources Development Group Ltd
SHE:200011
|
China | HK$13.40 Billion |
|
Mersana Therapeutics Inc
NASDAQ:MRSN
|
USA | $122.22 Million |
|
Bonduelle SAS
LSE:0N75
|
UK | €1.48 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Bonduelle SCA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bonduelle SCA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bonduelle SCA (2014–2025)
The table below shows the annual total liabilities of Bonduelle SCA from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €1.38 Billion | +6.49% |
| 2024-06-30 | €1.30 Billion | +6.68% |
| 2023-06-30 | €1.22 Billion | -3.41% |
| 2022-06-30 | €1.26 Billion | -14.68% |
| 2021-06-30 | €1.48 Billion | +0.98% |
| 2020-06-30 | €1.46 Billion | +5.53% |
| 2019-06-30 | €1.39 Billion | +0.44% |
| 2018-06-30 | €1.38 Billion | -4.71% |
| 2017-06-30 | €1.45 Billion | +33.26% |
| 2016-06-30 | €1.09 Billion | -8.36% |
| 2015-06-30 | €1.19 Billion | +1.98% |
| 2014-06-30 | €1.16 Billion | -- |